ABSTRACT WITHDRAWN - ECONOMIC EVALUATION OF 21-GENE ASSAY FOR EARLY STAGE BREAST CANCER PATIENTS FROM A PERSPECTIVE OF CHINESE HEALTH CARE SYSTEM - Withdrawal Notice | RetractBase